Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Commission To Review Tissue Products Draft Directive In December

This article was originally published in The Gray Sheet

Executive Summary

Eucomed is optimistic that European Union member states will adopt a proposed directive on tissue-engineered products, but the trade association notes that implementation probably will not occur before 2005

You may also be interested in...



Tissue Product Premarket Route, Legal Framework Debated By EU Regulators

The submission of European tissue product premarket filings to a "central expert body" comprising member state representatives is one of various review options explored by the European Commission in a July consultation document

Tissue Product Premarket Route, Legal Framework Debated By EU Regulators

The submission of European tissue product premarket filings to a "central expert body" comprising member state representatives is one of various review options explored by the European Commission in a July consultation document

MDA Merger Qualms Fuel Device Industry Critique Of EU Drug Directive

The medical device industry is steadily mounting resistance to the European Union's planned revisions to Directive 2001/83/EC on Medicinal Products for Human Use

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016686

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel